Skip to main content

Month: April 2021

Proactive news headlines including Twenty Seven Co, Piedmont Lithium, Theta Gold Mines and Archer Materials

Sydney, April 08, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Twenty Seven Co Ltd’s (ASX:TSC) (FRA:U9V) shares gained 33% after assays delivered up to 23 g/t gold and 33 g/t silver at Mt Dimer. Click here Piedmont Lithium Ltd (ASX:PLL) (NASDAQ:PLL) (OTCMKTS:PDDTF) has increased the global mineral resources estimate for its flagship Piedmont Lithium Project in North Carolina, USA, to 39.2 million tonnes at 1.09% lithium oxide. Click here Theta Gold Mines Ltd (ASX:TGM) (OTCMKTS:TGMGF) is trading higher after delivering a maiden underground mining reserve for the high-grade TGME Underground Project in South Africa – 490,000 ounces of gold at 5.49 g/t gold. Click here Archer Materials Ltd (ASX:AXE) (OTCMKTS:ARRXF)...

Continue reading

Byggmästare Anders J Ahlström Holding AB (publ): Ökar ägandet i Team Olivia

Byggmästare Anders J Ahlström Holding AB (”Byggmästaren”) har genom det helägda Byggmästare Anders J Ahlström Invest AB ökat ägandet i Team Olivia. Byggmästaren har förvärvat aktier motsvarande ytterligare 2,4 procent i Team Olivia Group AB, varefter Byggmästarens totala direkta ägande uppgår till 14,4 procent. Den nu tillkommande investeringen uppgår till ca 42 miljoner kronor, där en del avser förvärv av aktier och en del avser övertagna aktieägartillskott. Genom en tidigare investering i Procuritas fond PCI IV, vilken nu nästan uteslutande består av Team Olivia, äger Byggmästaren indirekt ytterligare ca 2,5 procent i Team Olivia. ”Team Olivia är ett välskött bolag med stark ledning och en genomtänkt strategi, som varje dag spelar en viktig roll för många människor i Sverige, Norge och Danmark. Byggmästaren känner bolaget väl och vi...

Continue reading

Meddelelse nr. 05/2021: Indre værdi pr. 31. marts 2021

  DATO DKKSeneste indre værdi 31-03-2021 1,00Indre værdi 28-02-2021 0,94Indre værdi 31-01-2021 0,94Indre værdi 31-12-2020 0,94Opgørelsen er baseret på samme regnskabspraksis som årsrapporten for 2020.Opgørelsen er ikke revideret. Der tages forbehold for endelig opgørelse. Med venlig hilsenStrategic Investments A/S Vedhæftet filSI_05_2021_NAV310321

Continue reading

Respiratory Drugs Market Size 2021 | Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape, Forecast Report 2021-2028

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) — Respiratory Drugs Market 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The rising adoption of innovative drugs for the treatment of various respiratory diseases is a key factor driving the global respiratory drugs, says Fortune Business Insights in a report, titled “Respiratory Drugs Market Size, Share & Industry Analysis, By Drug Class (Short-Acting Beta2-Agonists, Long-Acting Beta2-Agonists, Inhaled Corticosteroids, Anticholinergics, Antihistamines) By Disease Type (Asthma, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, Pleural Effusion), By Route of Administration (Inhalation, Enteral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Fore.” The surge in R&D...

Continue reading

Global Pulse Oximeters Market Size 2021 | to Reach USD 2,657.6 Million with CAGR of 6.7% by 2025

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) — Pulse Oximeter Market 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027, is latest report on Global Pulse Oximeter Industry, published by “Fortune Business Insights”. According to this report Global Pulse Oximeter Market to rise at healthy Compound Annual Growth Rate and will reach 2,657.6 Mn by 2027. Pulse Oximeter Market for Pulse Oximeter is segmented By Product Type (Fingertip Oximeters, Handheld Oximeters, Tabletop Oximeters) By End User (Hospitals, ASCs and Clinics, Home Healthcare) and Geography Forecast till 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period. iHealth’s Wristworn Pulse Oximeter to Witness Massive Demand iHealth’s wrist-worn pulse...

Continue reading

Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act

April 8, 2021Announcement no. 6 Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act The Company’s share capital has been increased by normally DKK 1,172,500, corresponding to 1,172,500 new shares, as a result of exercise of warrants issued under the Company’s incentive warrant program. Total proceeds from the capital increase amount to approximately DKK 4.4 million.The new shares have rights to dividends and other rights in the Company as from 8 April 2021. The new shares will be listed on Nasdaq Copenhagen, expectedly with first day of trading on 12 April 2021. After the share capital increase, the Company’s share capital amounts to nominally DKK 267,754,404 divided into 267,754,404 shares each carrying 1 voting right,...

Continue reading

Drill Programme Underway at United Downs Copper-Tin Project

VANCOUVER, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) — (“Cornish Metals” or the “Company”), is pleased to report that it has commenced diamond drilling at its United Downs copper-tin project in Cornwall UK. As stated previously, the objective of the drilling programme is to follow-up the high-grade copper-tin mineralisation in drill hole GWDD-002 that intersected 14.69 metres (“m”) at 8.45% copper (“Cu”) and 1.19% tin (“Sn”) (see news release dated April 6, 2020).The drilling programme has been contracted to Priority Drilling Ltd., under the supervision of Cornish Metals’ geological team; and The drill programme will be run with full COVID safe guidelines, policies and procedures in place.Richard Williams, CEO of Cornish Metals, stated, “We are all very excited to start this drill programme, following on from our successful...

Continue reading

Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients

SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced The Lancet Haematology has published the complete analysis of 72-week data from the Phase 3 HOPE Study of Oxbryta® (voxelotor) tablets in patients with sickle cell disease (SCD). The results showed significant and sustained improvement in hemoglobin levels, reduction in hemolysis and improved overall health status in patients treated with Oxbryta. These findings support the long-term use of Oxbryta to reduce hemolytic anemia and hemolysis in SCD, potentially mitigating life-threatening complications of the condition. Oxbryta, a first-in-class oral, once-daily therapy, directly inhibits hemoglobin polymerization, the root cause of the sickling and destruction of red blood cells in SCD. Oxbryta is approved...

Continue reading

Medium Voltage Cables Market to Register 7.4% CAGR till 2028; Rapid Urbanization Worldwide to Strengthen Market Growth: Fortune Business Insights™

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) — The global medium voltage cables market size is projected to reach USD 55.31 billion by 2028, exhibiting a CAGR of 7.4% during the forecast period. Fortune Business Insights™ shares this information in its report, titled “Medium Voltage Cables Market, 2021-2028”. As per the report, the value of the market stood at USD 31.47 billion in 2020. Government Initiatives Promoting Renewable Energy to Enhance Demand In the battle against global warming, governments across the world are launching initiatives to make renewable energy their primary resource for power-related requirements. For instance, Since February 2021, Singapore has initiated its project of building solar farms at Tengeh reservoir. These farms will be floating in the sea as the country lacks real estate. The project is handled...

Continue reading

Neonatal Intensive Care Respiratory Devices Market Size 2021 |To Reach USD 2,431.3 Million in 2028; Rising Respiratory Problems in Infants to Boost Growth, says Fortune Business Insights™

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) — The global “neonatal intensive care respiratory devices market is set to gain impetus from the increasing cases of preterm births. As per the World Health Organization (WHO), every year, around 15 million babies are born worldwide. Among them, 11% are preterm births. This information is given by Fortune Business Insights™ in a new report, titled, “Neonatal Intensive Care Respiratory Devices Market, 2021-2028.” The report further states that the neonatal intensive care respiratory devices market size is projected to grow from USD 1,636.2 million in 2021 to USD 2,431.3 million in 2028 at a CAGR of 5.8% in the forecast period. The COVID-19 pandemic has had a staggering impact on the market. It stood at USD 1,546.9 million in 2020. Neonatal intensive care respiratory devices exhibited normal...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.